Issue 1199: August 18, 2015

Ask the Experts
Ask the Experts—Question of the Week: Can teens receive Vaccines For Children (VFC) vaccines without a parent being…read more

CDC issues Vaccine Information Statement for serogroup B meningococcal vaccine

On August 14, CDC released a Vaccine Information Statement (VIS) for Serogroup B Meningococcal Vaccine (MenB). In November 2014, FDA announced the approval of Trumenba (Pfizer), and in January 2015, the approval of Bexsero (Novartis)—the first vaccines licensed in the United States to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B. Both Trumenba and Bexsero are licensed for use with people age 10 through 25 years. MenB brands are not interchangeable.

In February 2015, ACIP voted that a series of either of the licensed meningococcal B (MenB) vaccines should be administered to people 10 years of age and older who are at increased risk of meningococcal disease. These individuals include:
  • People with persistent complement component deficiencies, including inherited or chronic deficiencies in C3, C5-9, properdin, factor D, factor H, or taking eculizumab
  • People with anatomic or functional asplenia, including sickle cell disease
  • Microbiologists routinely exposed to isolates of Neisseria meningitidis
  • People identified to be at increased risk because of a meningococcal B outbreak
In addition, in June 2015, ACIP voted to recommend that a MenB vaccine series may be administered to persons 16 through 23 years of age with a preferred age of vaccination of 16 through 18 years. This Category B (permissive) recommendation allows for individual clinical decision-making, and will enable coverage of MenB vaccines by the Vaccines For Children program and most insurance plans.

ACIP stated no preference on the use of one MenB vaccine over the other.

Related Links Back to top

National Immunization Awareness Month's theme this week is adult vaccination

Every August, National Immunization Awareness Month (NIAM) provides an opportunity to raise awareness about the importance of immunization and the need for improving national vaccination coverage levels. Each week of NIAM focuses on the importance of immunization for a different audience. The week of August 16–22 will highlight adult vaccination, with the theme "Vaccines are not just for kids."

Take a look at the NIAM Communication Toolkit: Adults for ways to promote adult immunization.

Related Links Back to top

IAC Spotlight! One-stop access to more than 50 educational handouts related to adult vaccination for patients and staff

Looking for resources to promote adult vaccination this week in coordination with National Immunization Awareness Month? Look no further. IAC's Adult Vaccination Handouts section on features more than 50 educational pieces for health care professionals and their patients. From screening checklists to patient information materials, this collection helps you carry out your vaccination activities. Several patient handouts are also available in Spanish and other languages. 

Also, don’t miss IAC’s series of standing orders for adult vaccination; all are available at

Related Links
  • Handouts for Patients and Staff: Adult Vaccination
  1. Administering vaccines
  2. Documenting vaccination
  3. Patient-friendly schedules
  4. Screening questionnaires
  5. Standing orders
  6. Vaccine summaries
  7. Vaccine recommendation
Back to top

Register now for the CDC webinar series on "The Pink Book" chapter topics or listen to any of archived sessions soon; opportunity to earn continuing education credit ends 30 days after posting

CDC is presenting a 15-part webinar series to provide a chapter-by-chapter overview of the 13th edition of Epidemiology and Prevention of Vaccine-Preventable Diseases (also known as "The Pink Book"). This is a live series of one-hour webinars that started on July 8. All sessions begin at 12:00 p.m. (ET).

Continuing education credit will be available for each session. However, please note that continuing education will only be available for 30 days after each session is posted, so if you are interested in obtaining credit, plan accordingly.

Read more about the series.

Participation in this series requires advance registration. Virtual seats are available for the first 500 registrants, but each session will also be archived and available within two weeks after each event. The following five sessions are now archived and can be viewed online; a transcript of each broadcast is also available. Download Epidemiology and Prevention of Vaccine-Preventable Diseases Order Epidemiology and Prevention of Vaccine-Preventable Diseases
Order "The Pink Book" from the Public Health Foundation for $40 (plus shipping and handling)

Email CDC with comments, questions, or suggestions about the contents of this book.

Back to top

Vaccine Education Center plans September 16 Current Issues in Vaccines webinar

The Vaccine Education Center (VEC) at the Children's Hospital of Philadelphia, together with the Pennsylvania chapter of the American Academy of Pediatrics, will present a free one-hour webinar, beginning at noon (ET) on September 16. Continuing education credits will be available. Part of its Current Issues in Vaccines series, the webinar will feature Paul Offit, MD, director of VEC. Dr. Offit will discuss the following topics:
  • Meningococcal B vaccine: Who should get it?
  • California philosophical vaccine exemption change: What happens now?
  • HPV9 vaccine for persons who have completed an HPV vaccine series
Registration (required) is open now.

Back to top

IAC posts Khmer (Cambodian) translation of the Tdap VIS

IAC recently posted the VIS for Tdap vaccine in Khmer (Cambodian). IAC thanks the California Department of Public Health for this translation. Back to top

Now available! IAC's sturdy laminated versions of the 2015 U.S. child/teen immunization schedule and the 2015 U.S. adult immunization schedule—order a supply for your healthcare setting today!

IAC's laminated versions of the 2015 U.S. child/teen immunization schedule and the 2015 U.S. adult immunization schedule are covered with a tough, washable coating; they will stand up to a year's worth of use in every area of your healthcare setting where immunizations are given. The child and adolescent schedule has eight pages (i.e., four double-sided pages) and is folded to measure 8.5" x 11". The adult immunization schedule has six pages (i.e., three double-sided pages) and is folded to measure 8.5" x 11". Laminated Child and Teen Laminated Schedule Adult Laminated Immunization Schedules

Laminated schedules are printed in color for easy reading, come complete with essential tables and footnotes, and include contraindications and precautions—a feature that will help you make an on-the-spot determination about the safety of vaccinating patients of any age.

1–4 copies: $7.50 each
5–19 copies: $5.50 each
20–99 copies: $4.50 each
100–499 copies: $4.00 each
500–999 copies: $3.50 each

For quotes on customizing or placing orders for 1,000 copies or more, call (651) 647-9009 or email

You can access specific information on both schedules, view images of both, order online, or download an order form at the Shop IAC: Laminated Schedules web page.

Back to top

IAC makes available The Vaccine Handbook: A Practical Guide for Clinicians, a.k.a. "The Purple Book," by Dr. Gary Marshall

The Vaccine Handbook: A Practical Guide for Clinicians (“The Purple Book,” 2015, 560 pages) is a uniquely comprehensive source of practical, up-to-date information for vaccine providers and educators. Its author, Gary S. Marshall, MD, has drawn together the latest vaccine science and guidance into a concise, user-friendly, practical resource for the private office, public health clinic, academic medical center, and hospital.
Order your copy of The Vaccine Handbook today!
IAC Executive Director Deborah Wexler, MD, is enthusiastic about helping get this book circulated as widely as possible. “During more than 20 years in the field of immunization education, I have not seen a book that is so brimming with state-of-the-science vaccine information,” she states. "This book belongs in the hands of every medical student, physician-in-training, doctor, nursing student, and nurse who provides vaccines to patients.”
The Vaccine Handbook provides:
  • Information on every licensed vaccine in the United States
  • Rationale behind authoritative vaccine recommendations
  • Contingencies encountered in everyday practice
  • A chapter dedicated to addressing vaccine concerns
  • Background on how vaccine policy is made
  • Standards and regulations
  • Office logistics, including billing procedures, and much more
About the Author
Gary Marshall, MD, is professor of pediatrics at the University of Louisville School of Medicine in Kentucky, where he serves as chief of the division of pediatric infectious diseases and director of the Pediatric Clinical Trials Unit. In addition to being a busy clinician, he is nationally known for his work in the areas of vaccine research, advocacy, and education.

The newly released fifth edition of this invaluable guide is now available on IAC’s website at

The price of the handbook is $29.95 each, plus shipping charges. Discount pricing is available for more than 10 copies. Order copies for your staff or for distribution at an upcoming conference.

Quantity Discount Pricing
  • 1–10 books: no discount + shipping
  • 11–50 books: 5% + shipping
  • 51–100 books: 10% + shipping
  • 101–500 books: 15% + shipping
  • 501–1000 books: 20% + shipping
For quotes on larger quantities, email

Order your copy today! Back to top

NIH study finds children vaccinated before starting modern HIV therapy may lack immunity to measles, mumps, and rubella

A study by the National Institutes of Health (NIH) and CDC, which was published online in Clinical Infectious Diseases  on June 9, found that children and youth exposed to HIV in utero may not have sufficient immunity to ward off measles, mumps, and rubella even when appropriately vaccinated. The first two paragraphs of an NIH press release are reprinted below.

Between one-third and one-half of individuals in the United States who were infected with HIV around the time of birth may not have sufficient immunity to ward off measles, mumps, and rubella—even though they may have been vaccinated against these diseases. This estimate, from a National Institutes of Health research network, in collaboration with the Centers for Disease Control and Prevention, is based on a study of more than 600 children and youth exposed to HIV in the womb.

“Having a high level of immunity to measles, mumps, and rubella is important not only for an individual’s health, but also for preventing disease outbreaks in the larger community,” said the study’s first author, George K. Siberry, MD, Medical Officer in the Maternal and Pediatric Infectious Disease Branch of NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). “Individuals infected with HIV at birth who did not have the benefit of combined antiretroviral therapy before they were vaccinated should speak with their physician about whether they need a repeated course of the vaccine."

Related Links Back to top

Question of the Week

Can teens receive Vaccines For Children (VFC) vaccines without a parent being present? 

Each state has their own law as to the age limitations/requirements for a child 
to receive VFC services without parental consent.

About IAC's Question of the Week

Each week, IAC Express highlights a new, topical, or important-to-reiterate Q&A. This feature is a cooperative venture between IAC and CDC. William L. Atkinson, MD, MPH, IAC's associate director for immunization education, chooses a new Q&A to feature every week from a set of Q&As prepared by experts at CDC’s National Center for Immunization and Respiratory Diseases.

We hope you enjoy this new feature and find it helpful when dealing with difficult real-life scenarios in your vaccination practice. Please encourage your healthcare professional colleagues to sign up to receive IAC Express at

If you have a question for the CDC immunization experts, you can email them directly at There is no charge for this service.

Related Links Back to top

About IZ Express

IZ Express is supported in part by Grant No. 1NH23IP922654 from CDC’s National Center for Immunization and Respiratory Diseases. Its contents are solely the responsibility of and do not necessarily represent the official views of CDC.

IZ Express Disclaimer
ISSN 2771-8085

Editorial Information

  • Editor-in-Chief
    Kelly L. Moore, MD, MPH
  • Managing Editor
    John D. Grabenstein, RPh, PhD
  • Associate Editor
    Sharon G. Humiston, MD, MPH
  • Writer/Publication Coordinator
    Taryn Chapman, MS
    Courtnay Londo, MA
  • Style and Copy Editor
    Marian Deegan, JD
  • Web Edition Managers
    Arkady Shakhnovich
    Jermaine Royes
  • Contributing Writer
    Laurel H. Wood, MPA
  • Technical Reviewer
    Kayla Ohlde

This page was updated on .